Variables | Trial groups | |
---|---|---|
SP n = 94 | DP n = 112 | |
Mean age (years)a | 27.7 ± 6.1 | 27.3 ± 5.7 |
Age-group (years), n (%)b | ||
17–25 | 35 (37.2) | 50 (44.6) |
26–33 | 43 (46.7) | 43 (38.4) |
> 33 | 16 (17.1) | 19 (17.0) |
Mean gestational age in weeksa | 17.7 ± 1.7 | 17.4 ± 1.6 |
Gestation age in weeks, n (%)b | ||
16–17 | 54 (57.4) | 72 (64.3) |
18–20 | 40 (42.6) | 40 (35.7) |
Gravidity, n (%)b | ||
Primigravidae | 33 (35.1) | 38 (33.9) |
Multigravidae | 61 (64.9) | 74 (66.1) |
Mean weight (kg)a | 65.8 ± 14.8 | 63.6 ± 13.8 |
Mean height (m)a | 1.59 ± 0.07 | 1.59 ± 0.08 |
BMI (kg/m2), n (%)b | ||
< 18.5 | 6 (6.4) | 10 (9.0) |
18.5–24.9 | 40 (42.6) | 52 (46.4) |
> 24.9 | 48 (51.0) | 50 (44.6) |
Mean hemoglobin (g/dL)a | 10.3 ± 1.4 | 10.4 ± 1.4 |
Anemia, n (%)b | 41 (43.6) | 43 (38.4) |
Mean ALT level (IU/L)a | 11.5 ± 6.9 | 12.0 ± 7.9 |
Elevated ALT level (> 36 IU/L), n (%)cc | 1 (1.1) | 3 (2.7) |